Eng C - Search Results

1

Mutation analysis of NTRK2 and NTRK3, encoding 2 tyrosine kinase receptors, in sporadic human medullary thyroid carcinoma reveals novel sequence variants.

Gimm O, Dziema H, Brown J, de la Puente A, Hoang-Vu C, Dralle H, Plass C, Eng C. Gimm O, et al. Among authors: eng c. Int J Cancer. 2001 Apr 1;92(1):70-4. Int J Cancer. 2001. PMID: 11279608

2

Presymptomatic DNA screening in families with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma.

Frilling A, Dralle H, Eng C, Raue F, Broelsch CE. Frilling A, et al. Among authors: eng c. Surgery. 1995 Dec;118(6):1099-103; discussion 1103-4. doi: 10.1016/s0039-6060(05)80120-5. Surgery. 1995. PMID: 7491529

3

Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma.

Eng C, Mulligan LM, Smith DP, Healey CS, Frilling A, Raue F, Neumann HP, Ponder MA, Ponder BA. Eng C, et al. Clin Endocrinol (Oxf). 1995 Jul;43(1):123-7. doi: 10.1111/j.1365-2265.1995.tb01903.x. Clin Endocrinol (Oxf). 1995. PMID: 7641404

4

Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma.

Eng C, Mulligan LM, Healey CS, Houghton C, Frilling A, Raue F, Thomas GA, Ponder BA. Eng C, et al. Cancer Res. 1996 May 1;56(9):2167-70. Cancer Res. 1996. PMID: 8616867

5

Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma.

Eng C, Foster KA, Healey CS, Houghton C, Gayther SA, Mulligan LM, Ponder BA. Eng C, et al. Br J Cancer. 1996 Aug;74(3):339-41. doi: 10.1038/bjc.1996.363. Br J Cancer. 1996. PMID: 8695346 Free PMC article.

6

Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma.

Marsh DJ, Learoyd DL, Andrew SD, Krishnan L, Pojer R, Richardson AL, Delbridge L, Eng C, Robinson BG. Marsh DJ, et al. Among authors: eng c. Clin Endocrinol (Oxf). 1996 Mar;44(3):249-57. doi: 10.1046/j.1365-2265.1996.681503.x. Clin Endocrinol (Oxf). 1996. PMID: 8729519

7

Mutation analysis of glial cell line-derived neurotrophic factor (GDNF), a ligand for the RET/GDNF receptor alpha complex, in sporadic phaeochromocytomas.

Dahia PL, Toledo SP, Mulligan LM, Maher ER, Grossman AB, Eng C. Dahia PL, et al. Among authors: eng c. Cancer Res. 1997 Jan 15;57(2):310-3. Cancer Res. 1997. PMID: 9000574

8

Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation.

Gimm O, Marsh DJ, Andrew SD, Frilling A, Dahia PL, Mulligan LM, Zajac JD, Robinson BG, Eng C. Gimm O, et al. Among authors: eng c. J Clin Endocrinol Metab. 1997 Nov;82(11):3902-4. doi: 10.1210/jcem.82.11.4508. J Clin Endocrinol Metab. 1997. PMID: 9360560

9

Mutation of the RET proto-oncogene is correlated with RET immunostaining in subpopulations of cells in sporadic medullary thyroid carcinoma.

Eng C, Thomas GA, Neuberg DS, Mulligan LM, Healey CS, Houghton C, Frilling A, Raue F, Williams ED, Ponder BA. Eng C, et al. J Clin Endocrinol Metab. 1998 Dec;83(12):4310-3. doi: 10.1210/jcem.83.12.5345. J Clin Endocrinol Metab. 1998. PMID: 9851769

10

Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation.

Gimm O, Neuberg DS, Marsh DJ, Dahia PL, Hoang-Vu C, Raue F, Hinze R, Dralle H, Eng C. Gimm O, et al. Among authors: eng c. Oncogene. 1999 Feb 11;18(6):1369-73. doi: 10.1038/sj.onc.1202418. Oncogene. 1999. PMID: 10022819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,913 results

Search Page

Filters